HIV-1 viral protein R (VPR) and its interactions with host cell

Current HIV Research

Volumn 7, Issue 2, 2009, Pages 178-183

  Li, Ge ^a   Bukrinsky, Michael ^b   Zhao, Richard Y ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

EF2; Heat shock factors; HIV 1; Host cellular responses; Host pathogen interaction; Skp1 GSK3; Viral pathogenesis; Vpr

Indexed keywords

ANTIVIRUS AGENT; ELONGATION FACTOR 2; GLYCOGEN SYNTHASE KINASE 3; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 16; HEAT SHOCK PROTEIN 20; HEAT SHOCK PROTEIN 27; HEAT SHOCK PROTEIN 70; HEAT SHOCK TRANSCRIPTION FACTOR 1; NEVIRAPINE; STAVUDINE; UNCLASSIFIED DRUG; VPR PROTEIN; ZIDOVUDINE; VIRULENCE FACTOR; VPR PROTEIN, HUMAN IMMUNODEFICIENCY VIRUS 1;

AMINO ACID SUBSTITUTION; APOPTOSIS; CELL CYCLE G2 PHASE; CELLULAR IMMUNITY; CELLULAR STRESS RESPONSE; ENZYME ACTIVITY; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE TARGETING; HEAT SHOCK; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNE RESPONSE; INNATE IMMUNITY; MACROPHAGE; NONHUMAN; REVIEW; T LYMPHOCYTE; TRANSCRIPTION REGULATION; VIRUS CELL INTERACTION; VIRUS INHIBITION; VIRUS PATHOGENESIS; VIRUS REPLICATION; HOST PATHOGEN INTERACTION; PHYSIOLOGY;

HIV-1; HOST-PATHOGEN INTERACTIONS; HUMANS; VIRULENCE FACTORS; VPR GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS;

EID: 64749088422     PISSN: 1570162X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157016209787581436     Document Type: Review

References (74)

1. Bennasser Y, Le SY, Benkirane M, Jeang KT. Evidence that HIV-1 encodes an siRNA and a suppressor of RNA silencing. Immunity 2005; 22: 607-19.
2. Bishop KN, Holmes RK, Malim MH. Antiviral potency of APOBEC proteins does not correlate with cytidine deamination. J Virol 2006; 80: 8450-8.
3. Neil SJ, Zang T, Bieniasz PD. Tetherin inhibits retrovirus release and is antagonizedby HIV-1 Vpu. Nature 2008; 451: 425-30.
4. Tristem M, Purvis A, Quicke DL. Complex evolutionary history of primate, lentiviral vpr genes. Virology 1998; 240: 232-7.
5. Tristem M, Marshall C, Karpas A, Hill F. Evolution of the primate lentiviruses: evidence from vpx and vpr. EMBO J 1992; 11: 3405-12.
6. Heinzinger NK, Bukrinsky MI, Haggerty SA, et al. The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells. Proc Natl Acad Sci USA 1994; 91: 7311-5.
7. He J, Choe S, Walker R, Di Marzio P, Morgan DO, Landau NR. Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity. J Virol 1995; 69: 6705-11.
8. Li G, Elder RT, Qin K, Park HU, Liang D, Zhao RY. Phosphatase type 2A-dependent and -independent pathways for ATR phosphorylation of Chk1. J Biol Chem 2007; 282: 7287-98.
9. Re F, Braaten D, Franke EK, Luban J. Human immunodeficiency virus type 1 Vpr arrests the cell cycle in G2 by inhibiting the activation of p34cdc2-cyclin B. J Virol 1995; 69: 6859-64.
10. Stewart SA, Poon B, Jowett JB, Chen IS. Human immunodeficiency virus type 1 Vpr induces apoptosis following cell cycle arrest. J Virol 1997; 71: 5579-92.
11. Jowett JB, Planelles V, Poon B, Shah NP, Chen ML, Chen IS. The human immunodeficiency virus type 1 vpr gene arrests infected T cells in the G2 + M phase of the cell cycle. J Virol 1995; 69: 6304-13.
12. Goh WC, Rogel ME, Kinsey CM, et al. HIV-1 Vpr increases viral expression by manipulation of the cell cycle: a mechanism for selection of Vpr in viv. Nat Med 1998; 4: 65-71.
13. Benko Z, Liang D, Agbottah E, et al. Anti-Vpr activity of a yeast chaperone protein. J Virol 2004; 78: 11016-29.
14. Iordanskiy S, Zhao Y, DiMarzio P, Agostini I, Dubrovsky L, Bukrinsky M. Heat-shock protein 70 exerts opposing effects on Vpr-dependent and Vpr-independent HIV-1 replication in macrophages. Blood 2004; 104: 1867-72.
15. Di Marzio P, Choe S, Ebright M, Knoblauch R, Landau NR. Mutational analysis of cell cycle arrest, nuclear localization and virion packaging of human immunodeficiency virus type 1 Vpr. J Virol 1995; 69: 7909-16.
16. Connor RI, Chen BY, Choe S, Landau NR. Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes. Virology 1995; 206: 935-44.
17. Yamashita M, Perez O, Hope TJ, Emerman M. Evidence for direct involvement of the capsid protein in HIV infection of nondividing cells. PLoS Pathog 2007; 3: 1502-10.
18. Bouhamdan M, Xue Y, Baudat Y, et al. Diversity of HIV-1 Vpr interactions involves usage of the WXXF motif of host cell proteins. J Biol Chem 1998; 273: 8009-16.
19. Bukrinsky M. Inhibitors of the nuclear tianslocation of the HIV-1 preintegration complex. Drugs of the Future 1997; 22: 875-83.
20. Agostini I, Popov S, Li J, Dubrovsky L, Bukrinsky M. Heat-shock protein 70 can replace viral protein R of HIV-1 during nuclear import of the viral pre-integration complex. Exp Cell Res 2000; 259: 398-403.
21. Tristem M, Marshall C, Karpas A, Petrik J, Hill F. Origin of vpx in lentiviruses. Nature 1990, 347: 341-2.
22. Srivastava S, Swanson SK, Manel N, Florens L, Washburn MP, Skowronski J. Lentiviral Vpx Accessory Factor Targets VprBP/DCAF1 Substrate Adaptor for Cullin 4 E3 Ubiquitin Ligase to Enable Macrophage Infection. PLoS Pathogens 2008; 4: e1000059.
23. Sharova N, Wu Y, Zhu X, et al. Primate Lentiviral Vpx Commandeers DDB1 to Counteract a Macrophage Restriction. PLoS Pathogens 2008; 4: e 1000057.
24. Hrecka K, Gierszewska M, Srivastava S, et al. Lentiviral Vpr usurps Cul4-DDB1[VprBP] E3 ubiquitin ligase to modulate cell cycle. Proc Natl Acad Sci USA 2007; 104: 11778-83.
25. Mothe BR, Horton H, Carter DK, et al. Dominance of CD8 responses specific for epitopes bound by a single major histocompatibility complex class I molecule during the acute phase of viral infection. J Virol 2002; 76: 875-84.
26. Altfeld M, Addo MM, Eldridge RL, et al. Vpr is preferentially targeted by CTL during HIV-1 infection. J Immunol 2001; 167: 2743-52.
27. Benko Z, Liang D, Agbottah E, et al. Antagonistic interaction of HIV-1 Vpr with Hsf-mediated cellular heat shock response and Hsp 16 in fission yeast (Schizosaccharomyces pombe). Retrovirology 2007; 4:16-23.
28. Liang D, Benko Z, Agbottah E, Bukrinsky M, Zhao RY. Anti-vpr activities of heat shock protein 27. Mol Med 2007; 13: 229-39.
29. Zelivianski S, Liang D, Chen M, Mirkin BL, Zhao RY. Suppressive effect of elongation factor2 on apoptosis induced by HIV-1 viral protein R. Apoptosis 2006; 11: 377-88.
30. Huard S, Elder RT, Liang D, Li G, Zhao RY. Human immunodeficiency virus type 1 Vpr induces cell cycle G2 arrest through Srk1/MK2-mediated phosphorylation of Cdc25. J Virol 2008; 82: 2904-17.
31. van 't Wout AB, Lehrman GK, Mikheeva SA, et al. Cellular gene expression upon human immunodeficiency virus type 1 infection of CD4(+)-T-cell lines. J Virol 2003; 77: 1392-402.
32. Wainberg Z, Oliveira, M, Lerner S, Tao Y, Brenner BG. Modulation of stress protein (hsp27 and hsp70) expression in CD4+ lymphocytic cells following acute infection with human immunodeficiency virus type-1. Virology 1997; 233: 364-73.
33. Gu J, Emerman M, Sandmeyer S. Small heat shock protein suppression of Vpr-induced cytoskeletal defects in budding yeast. Mol Cell Biol 1997; 17: 4033-42.
34. Jorgensen R, Merrill AR, Andersen GR. The life and death of translation elongation factor 2. Biochem Soc Trans 2006; 34: 1-6.
35. Huard S, Chen M, Burdette KE, et al. HIV-1 Vpr-induced cell death in Schizosaccharomyces pombe is reminiscent of apoptosis. Cell Res 2008; 18: 961-73.
36. Frame S, Cohen P. GSK3 takes centre stage more than 20 years after its discovery. Biochem J 2001; 359: 1-16.
37. Jope RS, Johnson GV. The glamour and gloom of glycogen synthase kinase-3. Trends Biochem Sci 2004; 29: 95-102.
38. Beurel E, Jope RS. The paradoxical pro- and anti-apoptotic actions of GSK3 in the intrinsic and extrinsic apoptosis signaling pathways. Prog Neurobiol 2006; 79: 173-89.
39. Elder RT, Benko Z, Zhao Y. HIV-1 VPR modulates cell cycle G2/M transition through an alternative cellular mechanism other than the classic mitotic checkpoints. Front Biosci 2002; 7: d349-57.
40. Zhao Y, Elder RT. Yeast perspectives on HIV-1 VPR. Front Biosci 2000; 5: D905-16.
41. Zhao Y, Lieberman HB. Schizosaccharomyces pombe: a model for molecular studies of eukaryotic genes. DNA Cell Biol 1995; 14: 359-71.
42. Chen M, Elder RT, Yu M, et al. Mutational analysis of Vpr-induced G2 arrest, nuclear localization, and cell death in fission yeast. J Virol 1999; 73: 3236-45.
43. Elder RT, Yu M, Chen M, Edelson S, Zhao Y. Cell cycle G2 arrest induced by HIV-1 Vpr in fission yeast (Schizosaccharomyces pombe) is independent of cell death and early genes in the DNA damage checkpoint. Virus Res 2000; 68: 161-73.
44. Macreadie IG, Arunagiri CK, Hewish DR, White JF, Azad AA. Extracellular addition of a domain of HIV-1 Vpr containing the amino acid sequence motif H(S/F)RIG causes cell membrane permeabilization and death. Mol Microbiol 1996; 19: 1185-92.
45. Macreadie IG, Castelli LA, Hewish DR, Kirkpatrick A, Ward AC, Azad AA. A domain of human immunodeficiency virus type 1 Vpr containing repeated H(S/F)RIG amino acid motifs causes cell growth arrest and structural defects. Proc Natl Acad Sci USA 1995; 92: 2770-4.
46. Ciocca DR, Oesterreich S, Chamness GC, McGuire WL, Fuqua SA. Biological and clinical implications of heat shock protein 27, 000 (Hsp27): a review. J Natl Cancer Inst 1993; 85: 1558-70.
47. Brenner BG, Tao Y, Pearson E, Remer I, Wainberg MA. Altered constitutive and stress-regulated heat shock protein 27 expression in HIV type 1-infected cell lines. AIDS Res Hum Retroviruses 1995; 11: 713-7.
48. Brenner BG, Wainberg MA. Heat shock protein-based therapeutic strategies against human immunodeficiency virus type 1 infection. Infect Dis Obstet Gynecol 1999; 7: 80-90.
49. Iordanskiy S, Zhao Y, Dubrovsky L, et al. Heat shock protein 70 protects cells from cell cycle arrest and apoptosis induced by human immunodeficiency virus type 1 viral protein R. J Virol 2004; 78: 9697-704.
50. Sherman MP, de Noronha CM, Eckstein LA, et al. Nuclear export of Vpr is required for efficient replication of human immunodeficiency virus type 1 in tissue macrophages. J Virol 2003; 77: 7582-9.
51. Haffar OK, Popov S, Dubrovsky L, et al. Two nuclear localization signals in the HIV-1 matrix protein regulate nuclear import of the HIV-1 pre-integration complex. J Mol Biol 2000; 299: 359-68.
52. Jeoung DI, Chen S, Windsor J, Pollack RE. Human major HSP70 protein complements the localization and functional defects of cytoplasmic mutant SV40 T antigen in Swiss 3T3 mouse fibroblast cells. Genes Dev 1991; 5: 2235-44.
53. Vodicka MA. Determinants for lentiviral infection of non-dividing cells. Somat Cell Mol Genet 2001; 26: 35-49.
54. Katz RA, Greger JG, Boimel P, Skalka AM. Human immunodeficiency virus type 1 DNA nuclear import and integration are mitosis independent in cycling cells. J Virol 2003; 77: 13412-7.
55. Pirkkala L, Nykanen P, Sistonen L. Roles of the heat shock transcription factors in regulation of the heat shock response and beyond. FASEB J 2001; 15: 1118-31.
56. Mathew A, Mathur SK, Jolly C, Fox SG, Kim S, Morimoto RI. Stress-specific activation and repression of heat shock factors 1 and 2. Mol Cell Biol 2001; 21: 7163-71.
57. Trinklein ND, Chen WC, Kingston RE, Myers RM. Transcriptional regulation and binding of heat shock factor 1 and heat shock factor 2 to 32 human heat shock genes during thermal stress and differentiation. Cell Stress Chaperones 2004; 9: 21-8.
58. Addo MM, Yu XG, Rosenberg ES, Walker BD, Altfeld M. Cytotoxic T-lymphocyte (CTL) responses directed against regulatory and accessory proteins in HIV-1 infection. DNA Cell Biol 2002; 21: 671-8.
59. Ayyavoo V, Muthumani K, Kudchodkar S, et al. HIV-1 viral protein R compromises cellular immune function in vivo. Int Immunol 2002; 14: 13-22.
60. Abimiku AG, Franchini G, Aldrich K, et al. Humoral and cellular immune responses in rhesus macaques infected with human immunodeficiency virus type 2. AIDS Res Hum Retroviruses 1995; 11: 383-93.
61. Poon B, Grovit-Ferbas K, Stewart SA, Chen ISY. Cell cycle arrest by Vpr in HIV-1 virions and insensitivity to antiretroviral agents. Science 1998; 281: 266-9.
62. Muthumani K, Desai BM, Hwang DS, et al. HIV-1 Vpr and anti-inflammatory activity. DNA Cell Biol 2004; 23: 239-47.
63. Refaeli Y, Levy DN, Weiner DB. The glucocorticoid receptor type II complex is a target of the HIV-1 vpr gene product. Proc Natl Acad Sci USA 1995; 92: 3621-5.
64. Ayyavoo V, Mahboubi A, Mahalingam S, et al. HIV-1 Vpr suppresses immune activation and apoptosis through regulation of nuclear factor kappa B [see comments]. Nat Med 1997; 3: 1117-23.
65. Gallo GJ, Schuetz TJ, Kingston RE. Regulation of heat shock factor in Schizosaccharomyces pombe more closely resembles regulation in mammals than in Saccharomyces cerevisiae. Mol Cell Biol 1991; 11: 281-8.
66. Wang L, Mukherjee S, Jia F, Narayan O, Zhao LJ. Interaction of virion protein Vpr of human immunodeficiency virus type 1 with cellular transcription factor Sp1 and trans-activation of viral long terminal repeat. J Biol Chem 1995; 270: 25564-9.
67. Vodicka MA, Koepp DM, Silver PA, Emerman M. HIV-1 Vpr interacts with the nuclear transport pathway to promote macrophage infection. Genes Dev 1998; 12: 175-85.
68. Wurtzer S, Compain S, Benech H, Hance AJ, Clavel F. Effect of cell cycle arrest on the activity of nucleoside analogues against human immunodeficiency virus type 1. J Virol 2005; 79: 14815-21.
69. Olivero OA. Mechanisms of genotoxicity of nucleoside reverse transcriptase inhibitors. Environ Mol Mutagen 2007; 48: 215-23.
70. Heredia A, Amoroso A, Davis C, et al. Rapamycin causes down-regulation of CCR5 and accumulation of anti-HIV beta-chemokines: an approach to suppress R5 strains of HIV-1. Proc Natl Acad Sci USA 2003; 100: 10411-6.
71. Heredia A, Davis C, Amoroso A, et al. Induction of G1 cycle arrest in T lymphocytes results in increased extracellular levels of beta-chemokines: a strategy to inhibit R5 HIV-1. Proc Natl Acad Sci USA 2003; 100: 4179-84.
72. Heredia A, Davis C, Redfield R. Synergistic inhibition of HIV-1 in activated and resting peripheral blood mononuclear cells, monocyte-derived macrophages, and selected drug-resistant isolates with nucleoside analogues combined with a natural product, resveratrol. J Acquir Immune Defic Syndr 2000; 25: 246-55.
73. Yao XJ, Lemay J, Rougeau N, et al. Genetic selection of peptide inhibitors of human immunodeficiency virus type 1 Vpr. J Biol Chem 2002; 277: 48816-26.
74. Elder RT, Yu M, Chen M, Zhu X, Yanagida M, Zhao Y. HIV-1 Vpr induces cell cycle G2 arrest in fission yeast (Schizosaccharomyces pombe) through a pathway involving regulatory and catalytic subunits of PP2A and acting on both Wee1 and Cdc25. Virology 2001; 287: 359-70.